FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michel Burnier

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Geographic Areas

Seychelles

Procedures

Cross-Over Studies

Concepts & Ideas

Activities & Behaviors

Patient Compliance

Co-author Network

Publications

TOP 3
Grégoire Wuerzner; Carole Zweiacker; Murielle Bochud; Menno Pruijm; Sylvie Tremblay; Michel Burnier
Step count is associated with lower nighttime systolic blood pressure and increased dipping.
Menno Pruijm; Daniel Teta; Youssef El-Housseini; Jamil Hachicha; Faiçal Jarraya; Hichem Mahfoudh; Michel Burnier
Stimulated sweating as a therapy to reduce interdialytic weight gain and improve potassium balance in chronic hemodialysis patients: a pilot study.
Arnaud Chiolero; Pascal Bovet; Michel Burnier
Oscillometric blood pressure reference values in children.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michel Burnier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Grégoire Wuerzner; Carole Zweiacker; Murielle Bochud; Menno Pruijm; Sylvie Tremblay; Michel Burnier
Step count is associated with lower nighttime systolic blood pressure and increased dipping.
American journal of hypertension 2013;26(4):527-34.
2013: Menno Pruijm; Daniel Teta; Youssef El-Housseini; Jamil Hachicha; Faiçal Jarraya; Hichem Mahfoudh; Michel Burnier
Stimulated sweating as a therapy to reduce interdialytic weight gain and improve potassium balance in chronic hemodialysis patients: a pilot study.
Hemodialysis international. International Symposium on Home Hemodialysis 2013;17(2):240-8.
2013: Arnaud Chiolero; Pascal Bovet; Michel Burnier
Oscillometric blood pressure reference values in children.
Journal of hypertension 2013;31(2):426.
2013: Menno Pruijm; Matthias Stuber; Bruno Vogt; Grégoire Wuerzner; Anne Zanchi; Valentina Forni; Lucie Hofmann; Marc Maillard; Marie-Eve Muller; Michel Burnier
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.
Diabetes research and clinical practice 2013;99(2):136-44.
2013: Arnaud Chiolero; Katerina Maximova; Gilles Paradis; Michel Burnier; Pascal Bovet
No use for waist-for-height ratio in addition to body mass index to identify children with elevated blood pressure.
Blood pressure 2013;22(1):17-20.
2012: Menno Pruijm; Pascale Roux-Lombard; Jan Schmidtko; Daniel Teta; Anthony Aho; Michel Burnier; Sabrina Pagano; Nicolas Vuilleumier
High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(6):588-94.
2012: Youssef El-Housseini; Jamil Hachicha; Fayçal Jarraya; Hichem Mahfoudh; Michel Burnier; Daniel Teta; Menno Pruijm
[Stimulated sweating in order to improve the water-and-salt balance in hemodialysis patients. A case report].
Néphrologie & thérapeutique 2012;8(6):472-5.
2012: Michel Burnier
Blood pressure in hospitalized patients: should we still measure it?
Journal of hypertension 2012;30(10):1913-4.
2012: Dai-Hua Tsai; Peter Vollenweider; Grégoire Wuerzner; Michel Burnier; Marc Maillard; Pedro Marques-Vidal; Fred Paccaud; Michael Riediker; Murielle Bochud
Short-term increase in particulate matter blunts nocturnal blood pressure dipping and daytime urinary sodium excretion.
Hypertension 2012;60(4):1061-9.
2012: Valérie Santschi; Grégoire Wuerzner; Bernard Burnand; Arnaud Chiolero; G Paradis; Michel Burnier
[Team-based care involving pharmacists and nurses to improve the management of hypertension].
Revue médicale suisse 2012;8(353):1694-6, 1698.
2012: Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Should hypertensive patients take vitamin D?
Current hypertension reports 2012;14(4):318-23.
2012: Jerome Aellen; Michel Burnier; Amin Dabiri; François Feihl; Abigael Heim; Lucas Liaudet; Juan Ruiz; Bernard Waeber
Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes.
Microcirculation (New York, N.Y. : 1994) 2012;19(6):554-62.
2012: Murielle Bochud; Michel Burnier; P Marques-Vidal; Fred Paccaud
[Population reduction of salt consumption: opportunities, impact and strategies].
Revue médicale suisse 2012;8(348):1443-7.
2012: Qing Wang; Johanns Weber; Ju Chen; Andrea Domenighetti; Hans-Anton Lehr; Marc P Maillard; Thierry Pedrazzini; Stephan C Schäfer; Alexandra Simon; Michel Burnier
Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
American journal of physiology. Regulatory, integrative and comparative physiology 2012;302(9):R1025-33.
2012: Menno Pruijm; Peter Vollenweider; Gérard Waeber; Michel Burnier; Pedro Marques-Vidal; Vincent Mooser; Fred Paccaud; Belén Ponte; Murielle Bochud
Not all inflammatory markers are linked to kidney function: results from a population-based study.
American journal of nephrology 2012;35(3):288-94.
2012: Alain Rossier; Michel Burnier; Dores Hannane; Menno Pruijm; Daniel Teta
Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(1):352-7.
2011: Anne Zanchi; Michel Burnier; Antoinette Pechère-Bertschi; Olivier Bonny
Effects of pioglitazone on renal calcium excretion.
The Journal of clinical endocrinology and metabolism 2011;96(9):E1482-5.
2011: V Santschi; Michel Burnier; Isabelle Peytremann Bridevaux
[Do elderly hypertensive patients benefit from drug therapy?].
Praxis 2011;100(12):731-2.
2011: Michel Burnier; Grégoire Wuerzner
Pharmacokinetic evaluation of losartan.
Expert opinion on drug metabolism & toxicology 2011;7(5):643-9.
2011: Laila-Yasmin Mani; Bruno Vogt; Michel Burnier; Déla Golshayan
[Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Revue médicale suisse 2011;7(290):819-24.
2011: Michel Burnier; Y Brede; A Lowy
Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril.
International journal of clinical practice 2011;65(2):127-33.
2011: Michel Burnier; Grégoire Wuerzner
Lowering systolic blood pressure below 130 mm Hg does not improve cardiovascular outcomes in hypertensive patients with diabetes and coronary artery disease.
Evidence-based medicine 2011;16(1):24-6.
2011: Grégoire Wuerzner; Michel Burnier; Bernard Waeber
[Hypertension and vitamin D: not again].
Revue médicale suisse 2011;7(278):121-4.
2011: Valentina Forni; Menno Pruijm; Grégoire Wuerzner; Michel Burnier
Long-term use and tolerability of irbesartan for control of hypertension.
Integrated blood pressure control 2011;4():17-26.
2011: Grégoire Wuerzner; Vittorio Giusti; Murielle Bochud; Michel Burnier
Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.
Obesity facts 2011;4(3):238-43.
2011: Roberto Bullani; Youssef El-Housseini; Fabrice Giordano; Anna Larcinese; Lorella Ciutto; Pauline Coti Bertrand; Grégoire Wuerzner; Michel Burnier; Daniel Teta
Effect of intradialytic resistance band exercise on physical function in patients on maintenance hemodialysis: a pilot study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2011;21(1):61-5.
2010: Qing Wang; Marc Maillard; Ueli Schibler; Michel Burnier; Frédéric Gachon
Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF.
American journal of physiology. Regulatory, integrative and comparative physiology 2010;299(4):R1013-9.
2010: V Forni; Grégoire Wuerzner; M Pruijm; L Guihard; Michel Burnier
[Managing hypertension: the uncertainty of definitions and targets].
Revue médicale suisse 2010;6(262):1709-12, 1714.
2010: Grégoire Wuerzner; Menno Pruijm; Marc Maillard; Pascal Bovet; Claude Renaud; Michel Burnier; Murielle Bochud
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;56(2):303-12.
2010: Menno Pruijm; Lucie Hofmann; Marc Maillard; Sylvie Tremblay; Nicolas Glatz; Grégoire Wuerzner; Michel Burnier; Bruno Vogt
Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men.
Hypertension 2010;55(5):1116-22.
2010: Murielle Bochud; Michel Burnier; Pedro Marques-Vidal; Fred Paccaud
[Reducing dietary salt intake: an important public health strategy in Switzerland].
Revue médicale suisse 2010;6(239):494, 496-8.
2010: Lorenzo Berwert; Bruno Vogt; Michel Burnier
[Hypernatremia: a matter of water].
Revue médicale suisse 2010;6(238):444-7.
2010: Niels Gobin; Lionel Coltamai; Michel Burnier; Bruno Vogt
[Resistance to loop diuretics in clinical practice].
Revue médicale suisse 2010;6(238):438-42.
2010: Raphaël Simon; Lorenzo Berwert; Michel Burnier; Daniel Teta
[Severe renal insufficiency secondary to renal cholesterol emboli: therapeutical options revisited].
Revue médicale suisse 2010;6(238):432-4, 436-7.
2010: Michel Burnier
Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill.
Integrated blood pressure control 2010;3():57-62.
2009: Bruno Vogt; Michel Burnier
Aldosterone and cardiovascular risk.
Current hypertension reports 2009;11(6):450-5.
2009: Murielle Bochud; Pascal Bovet; Peter Vollenweider; Marc Maillard; Fred Paccaud; Gilles Wandeler; Anne Gabriel; Michel Burnier
Association between white-coat effect and blunted dipping of nocturnal blood pressure.
American journal of hypertension 2009;22(10):1054-61.
2009: Marc Maillard; Andrée Tedjani; Christine Perregaux; Michel Burnier
Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat.
Journal of hypertension 2009;27(10):1980-7.
2009: N Glatz; Grégoire Wuerzner; M Pruijm; D Golshayan; Michel Burnier
[Hypertension in solid organ transplants].
Revue médicale suisse 2009;5(216):1771-4, 1776-7.
2009: M Pruijm; Murielle Bochud; Michel Burnier
[Hypertension genetics: what have we learned so far?].
Revue médicale suisse 2009;5(216):1763-4, 1766-8, 1770.
2009: M Pruijm; Daniel Teta; Georges Halabi; Grégoire Wuerzner; Valérie Santschi; Michel Burnier
Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patients.
Clinical nephrology 2009;72(3):199-205.
2009: Yu Jin; Tatiana Kuznetsova; Marc Maillard; Tom Richart; Lutgarde Thijs; Murielle Bochud; Marie-Christine Herregods; Michel Burnier; Robert Fagard; Jan A Staessen
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone.
Hypertension 2009;54(3):489-95.
2009: Michel Burnier; Menno Pruijm; Gregoire Wuerzner
Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Expert opinion on drug metabolism & toxicology 2009;5(8):981-7.
2009: Michel Burnier; Jacques A Douchamps; Ann Tanghe; Jan Demey; Louise Perrault; Claire E Foster; Sean Robbins
Less frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study.
Journal of medical economics 2009;12(2):77-86.
2009: Pascal Meier; Dela Golshayan; Edouard Blanc; Manuel Pascual; Michel Burnier
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
Journal of the American Society of Nephrology : JASN 2009;20(6):1368-84.
2009: J Smolander; B Vogt; Marc Maillard; C Zweiacker; T Littke; T Hengelage; Michel Burnier
Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.
Clinical pharmacology and therapeutics 2009;85(6):628-34.
2009: Murielle Bochud; Pascal Bovet; Michel Burnier; Chin B Eap
CYP3A5 and ABCB1 genes and hypertension.
Pharmacogenomics 2009;10(3):477-87.
2009: Murielle Bochud; Jan A Staessen; Marc Maillard; Muzi J Mazeko; Tatiana Kuznetsova; Angela Woodiwiss; Tom Richart; Gavin Norton; Lutgarde Thijs; Robert Elston; Michel Burnier
Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations.
Journal of hypertension 2009;27(3):606-12.
2009: L Coltamai; M Bucher; M P Maillard; U Shukla; N Bohidar; L Haskell; K Bertelsen; M Fedgchin; B Vogt; Michel Burnier
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
Clinical pharmacology and therapeutics 2009;85(2):145-8.
2008: M T Pruijm; B Vogt; A Cherpillod; Michel Burnier
[Plasmapheresis, a safe treatment when applied to the correct indication and with awareness of the complications].
Nederlands tijdschrift voor geneeskunde 2008;152(42):2261-6.
2008: Bruno Vogt; Pascal Meier; Michel Burnier
[Retroperitoneal fibrosis, M. Ormond, periaoartitis, ...?].
Therapeutische Umschau. Revue thérapeutique 2008;65(5):265-8.
2008: Paolo Manunta; Marc Maillard; Cristina Tantardini; Marco Simonini; Chiara Lanzani; Lorena Citterio; Paola Stella; Nunzia Casamassima; Michel Burnier; John M Hamlyn; Giuseppe Bianchi
Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
Journal of hypertension 2008;26(5):914-20.
2008: Menno T Pruijm; George Madeleine; Walter Riesen; Michel Burnier; Pascal Bovet
Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers.
Journal of hypertension 2008;26(5):871-7.
2008: Michel Burnier
Alterations of renal sodium handling in arterial hypertension.
Current hypertension reports 2008;10(2):85-6.
2008: Daniel Teta; Marc Maillard; Georges Halabi; Michel Burnier
The leptin/adiponectin ratio: potential implications for peritoneal dialysis.
Kidney international. Supplement 2008;(108):S112-8.
2008: Olivier Bonny; Michel Burnier
[Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].
Revue médicale suisse 2008;4(147):589-92, 594-5.
2008: Menno T Pruijm; Daniel Teta; Grégoire Wuerzner; Valérie Santschi; Michel Burnier
[Treatment of secondary hyperparathyroidism in dialysis: Report of a case-study of treatment failure].
Néphrologie & thérapeutique 2008;4(1):28-33.
2008: Menno T Pruijm; Marc Maillard; Michel Burnier
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.
Vascular health and risk management 2008;4(6):1159-66.
2008: Claudine M Mathieu; Daniel Teta; Nathalie Lötscher; Dela Golshayan; Luca Gabutti; Denes Kiss; Pierre-Yves Martin; Michel Burnier
Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland.
BMC nephrology 2008;9():16.
2008: Michel Burnier; Urs E Gasser
End-digit preference in general practice: a comparison of the conventional auscultatory and electronic oscillometric methods.
Blood pressure 2008;17(2):104-9.
2008: Murielle Bochud; Chin B Eap; Marc Maillard; Toby Johnson; Peter Vollenweider; Pascal Bovet; Robert C Elston; Sven Bergmann; Jacques Beckmann; Dawn M Waterworth; Vincent Mooser; Anne Gabriel; Michel Burnier
Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.
BMC medical genomics 2008;1():21.
2008: Pascal Bovet; Arnaud Chiolero; Michel Burnier; Fred Paccaud
Need to clarify when measurements should be made during the day for home blood pressure monitoring.
Journal of hypertension 2008;26(1):154-5.
2007: Valérie Santschi; Grégoire Wuerzner; Marie-Paule Schneider; Olivier Bugnon; Michel Burnier
Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring.
European journal of clinical pharmacology 2007;63(12):1179-84.
2007: Arnaud Chiolero; François Cachat; Michel Burnier; Fred Paccaud; Pascal Bovet
Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight.
Journal of hypertension 2007;25(11):2209-17.
2007: Michel Burnier; Urs E Gasser
Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice.
Expert opinion on pharmacotherapy 2007;8(14):2215-23.
2007: Alexia Charmoy; Grégoire Würzner; Christiane Ruffieux; Christopher Hasler; François Cachat; Bernard Waeber; Michel Burnier
Reactive rise in blood pressure upon cuff inflation: cuff inflation at the arm causes a greater rise in pressure than at the wrist in hypertensive patients.
Blood pressure monitoring 2007;12(5):275-80.
2007: Michel Burnier; Lionel Coltamai; Marc Maillard; Murielle Bochud
Renal sodium handling and nighttime blood pressure.
Seminars in nephrology 2007;27(5):565-71.
2007: Michel Burnier
Improving blood pressure control in the community: can new technologies help us?
American journal of hypertension 2007;20(9):949.
2007: Michel Burnier; Olivier Phan; Qing Wang
High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(9):2426-9.
2007: Anne Zanchi; Abdul G Dulloo; Christine Perregaux; Jean-Pierre Montani; Michel Burnier
Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties.
American journal of physiology. Endocrinology and metabolism 2007;293(1):E91-5.
2007: Murielle Bochud; Jan A Staessen; Angela J Woodiwiss; Gavin Norton; Marc Maillard; Michel Burnier
Context dependency of serum and urinary lithium: implications for measurement of proximal sodium reabsorption.
Hypertension 2007;49(5):e34.
2007: Chin B Eap; Murielle Bochud; Robert C Elston; Pascal Bovet; Marc Maillard; Jürg Nussberger; Laurent Schild; Conrad Shamlaye; Michel Burnier
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Hypertension 2007;49(5):1007-14.
2007: Pascal Meier; Jérôme Rossert; Pierre-François Plouin; Michel Burnier
Atherosclerotic renovascular disease: beyond the renal artery stenosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(4):1002-6.
2007: Nicolas Rodondi; Patrick Yerly; Anne Gabriel; Walter Riesen; Michel Burnier; Fred Paccaud; Pascal Bovet
Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(4):1107-14.
2007: D Golshayan; C Mathieu; Michel Burnier
[Pregnancy in patients with underlying renal disease].
Revue médicale suisse 2007;3(101):588, 590-2, 594-5.
2007: Daniel Teta; Marc Maillard; Andrée Tedjani; Jutta Passlick-Deetjen; Michel Burnier
The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(3):862-9.
2007: Arnaud Chiolero; George Madeleine; Anne Gabriel; Michel Burnier; Fred Paccaud; Pascal Bovet
Prevalence of elevated blood pressure and association with overweight in children of a rapidly developing country.
Journal of human hypertension 2007;21(2):120-7.
2007: Pascal Meier; François Spertini; Edouard Blanc; Michel Burnier
Oxidized low-density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement.
Journal of the American Society of Nephrology : JASN 2007;18(1):331-42.
2006: Anne Zanchi; Christine Perregaux; Marc Maillard; Daniel Cefai; Jürg Nussberger; Michel Burnier
The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
American journal of physiology. Endocrinology and metabolism 2006;291(6):E1228-34.
2006: Michel Burnier
Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.
American journal of hypertension 2006;19(11):1190-6.
2006: Jitka Seidlerová; Jan A Staessen; Marc Maillard; Tim Nawrot; Haifeng Zhang; Murielle Bochud; Tatiana Kuznetsova; Tom Richart; Luc M Van Bortel; Harry A J Struijker Boudier; Paolo Manunta; Michel Burnier; Robert Fagard; Jan Filipovský
Association between arterial properties and renal sodium handling in a general population.
Hypertension 2006;48(4):609-15.
2006: Michèle Senn; Bernard Favrat; Paul Vaucher; Michel Burnier
Physicians' estimates of the 10 year cardiovascular risk in hypertensive patients: an evaluation in primary care physicians in training.
Swiss medical weekly 2006;136(37-38):603-8.
2006: Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Plasma aldosterone is independently associated with the metabolic syndrome.
Hypertension 2006;48(2):239-45.
2006: Murielle Bochud; Chin B Eap; Robert C Elston; Pascal Bovet; Marc Maillard; Laurent Schild; Conrad Shamlaye; Michel Burnier
Association of CYP3A5 genotypes with blood pressure and renal function in African families.
Journal of hypertension 2006;24(5):923-9.
2006: Michel Burnier; Murielle Bochud; Marc Maillard
Proximal tubular function and salt sensitivity.
Current hypertension reports 2006;8(1):8-15.
2006: Grégoire Wuerzner; Michel Burnier
Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2006;24(1):S89-93.
2006: D Golshayan; Jean-Pierre Venetz; François Cachat; F Fellmann; S Moll; Michel Burnier; Frédéric Barbey
[Clinical and genetics aspects of Alport syndrome].
Revue médicale suisse 2006;2(55):593-8.
2006: Jean-Christophe Luthi; W Dana Flanders; Michel Burnier; Bernard Burnand; William M McClellan
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.
BMC nephrology 2006;7():3.
2006: Pierre Landry; Danila Iorillo; Roger Darioli; Michel Burnier; Blaise Genton
Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox.
Journal of travel medicine 2006;13(1):8-14.
2005: C Mathieu; P Meier; A Meyer zu Starten; Michel Burnier
[Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?].
Praxis 2005;94(47):1851-8.
2005: Christopher Hasler; Jürg Nussberger; Marc Maillard; Andrei Forclaz; Hans R Brunner; Michel Burnier
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 2005;78(5):501-7.
2005: Jan A Staessen; Tatiana Kuznetsova; Rok Acceto; Antonella Bacchieri; Eva Brand; Michel Burnier; Hilde Celis; Lorena Citterio; Peter W de Leeuw; Jan Filipovský; Albert Fournier; Kalina Kawecka-Jaszcz; Paolo Manunta; Yuri Nikitin; Eoin T O'Brien; Josep Redón; Lutgarde Thijs; Patrizia Ferrari; Giovanni Valentini; Giuseppe Bianchi
OASIS-HT: design of a pharmacogenomic dose-finding study.
Pharmacogenomics 2005;6(7):755-75.
2005: Grégoire Wuerzner; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Michel Burnier
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.
Kidney international 2005;68(2):688-94.
2005: Daniel Teta; Andrée Tedjani; Michel Burnier; Alan Bevington; Jeremy Brown; Kevin Harris
Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(7):1329-35.
2005: Michel Burnier
The safety of rofecoxib.
Expert opinion on drug safety 2005;4(3):491-9.
2005: Murielle Bochud; Pascal Bovet; Robert C Elston; Fred Paccaud; Catherine Falconnet; Marc Maillard; Conrad Shamlaye; Michel Burnier
High heritability of ambulatory blood pressure in families of East African descent.
Hypertension 2005;45(3):445-50.
2005: Grégoire Wuerzner; S Taddei; Jean-Yves Meuwly; François Cachat; Michel Burnier; Frédéric Barbey
[Diagnosis of renal cysts].
Revue médicale suisse 2005;1(8):534-8, 541-2.
2005: Pascal Meier; Marc Maillard; Michel Burnier
The future of angiotensin II inhibition in cardiovascular medicine.
Current drug targets. Cardiovascular & haematological disorders 2005;5(1):15-30.
2005: Christopher Hassler; Michel Burnier
Circadian variations in blood pressure : implications for chronotherapeutics.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(1):7-15.
2005: Murielle Bochud; Robert C Elston; Marc Maillard; Pascal Bovet; Laurent Schild; Conrad Shamlaye; Michel Burnier
Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean).
Kidney international 2005;67(1):61-9.
2004: Frédéric Barbey; François Cachat; Quan-Vinh Nguyen; Samuel Rotman; Michel Burnier; Michel Daudon
[Massive hyperoxaluria].
Revue médicale de la Suisse romande 2004;124(8):477-82.
2004: Frédéric Barbey; François Cachat; Patrice Jichlinski; Michel Burnier
[Urinary calculi].
Revue médicale de la Suisse romande 2004;124(8):432.
2004: Catherine Falconnet; Murielle Bochud; Pascal Bovet; Marc Maillard; Michel Burnier
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent.
Journal of hypertension 2004;22(6):1213-20.
2004: Murielle Bochud; Michel Burnier; Fred Paccaud; Catherine Falconnet; Vincent Mooser; Norma Both; Pascal Bovet
Patients' sibling history was sensitive for hypertension and specific for diabetes.
Journal of clinical epidemiology 2004;57(5):497-501.
2004: Arnaud Chiolero; Jean-Pierre Gervasoni; Anne Rwebogora; Mashombo Mkamba; Bernard Waeber; Fred Paccaud; Michel Burnier; Pascal Bovet
Discordant prevalence of hypertension using two different automated blood pressure measurement devices: a population-based study in Dar es Salaam (Tanzania).
Blood pressure monitoring 2004;9(2):59-64.
2004: D Conen; V Wietlisbach; Pascal Bovet; Conrad Shamlaye; Walter Riesen; Fred Paccaud; Michel Burnier
Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.
BMC public health 2004;4():9.
2004: Anne Zanchi; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
The Journal of clinical endocrinology and metabolism 2004;89(3):1140-5.
2004: Qing Wang; Hans R Brunner; Michel Burnier
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter.
American journal of physiology. Heart and circulatory physiology 2004;286(2):H806-14.
2004: Frédéric Barbey; G Nseir; C Ferrier; Michel Burnier; Michel Daudon
[Carbonic anhydrase inhibitors and calcium phosphate stones].
Néphrologie 2004;25(5):169-72.
2004: Grégoire Wuerzner; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier; Arnaud Chiclero
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Kidney international 2004;65(1):238-44.
2003: Frédéric Barbey; C Matthieu; G Nseir; Michel Burnier; D Teta
A young man with a renal colic.
Journal of internal medicine 2003;254(6):605-8.
2003: Marie-Paule Schneider; Guy van Melle; Christophe Uldry; Marc Huynh-Ba; Claire-Lise Fallab-Stubi; Danila Iorillo; Michel Burnier; Jean-Pierre Zellweger
Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2003;5(5):719-27.
2003: Frédéric Barbey; Olivier Bonny; Laura Rothuizen; Fulgencio Gomez; Michel Burnier
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(10):2193-6.
2003: Kaisa Wuerzner; Christophe Hassler; Michel Burnier
Difficult blood pressure control: watch out for non-compliance!
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(10):1969-73.
2003: Anne Zanchi; Marc Maillard; Michel Burnier
Recent clinical trials with omapatrilat: new developments.
Current hypertension reports 2003;5(4):346-52.
2003: Michel Burnier; Valérie Santschi; Bernard Favrat; Hans R Brunner
Monitoring compliance in resistant hypertension: an important step in patient management.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S37-42.
2003: Pascal Bovet; Jean-Pierre Gervasoni; Allen G Ross; Mashombo Mkamba; Deo Mtasiwa; Christian Lengeler; Michel Burnier; Fred Paccaud
Assessing the prevalence of hypertension in populations: are we doing it right?
Journal of hypertension 2003;21(3):509-17.
2003: Maurice Matter; Jean-Pierre Venetz; Vincent Aubert; C Gachet; Michel Burnier; Frédéric Barbey
Dual transplant of marginal kidneys. Case report and review of the literature.
Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera 2003;9(5):213-5.
2003: Andrei Forclaz; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension 2003;41(1):31-6.
2002: Michel Burnier; Valérie Santschi; Claire-Lise Fallab-Stubi; Arnaud Chiolero; Marie-Pierre Schneider; Bernard Favrat
[Hypertension -- therapeutic observation: the medical impression of telemetry].
Revue médicale de la Suisse romande 2002;122(10):467-70.
2002: Frédéric Regamey; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Hypertension 2002;40(3):266-72.
2002: Pasal Vuilleumier; Dumeng Decosterd; Marc Maillard; Michel Burnier; Daniel Hayoz
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population.
Journal of hypertension 2002;20(9):1753-7.
2002: Marc Maillard; Christine Perregaux; Catherine Centeno; Joachim Stangier; Wolfgang Wienen; Hans R Brunner; Michel Burnier
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2002;302(3):1089-95.
2002: Qing Wang; Edith Hummler; Jürg Nussberger; Sophie Clément; Giulio Gabbiani; Hans R Brunner; Michel Burnier
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Journal of the American Society of Nephrology : JASN 2002;13(6):1509-16.
2002: Arnaud Chiolero; Marc Maillard; Michel Burnier
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
Expert opinion on drug safety 2002;1(1):45-52.
2002: Arnaud Chiolero; Valérie Santschi; Michel Burnier
[Treatment compliance, key element in the management of arterial hypertension].
Revue médicale de la Suisse romande 2002;122(5):237-40.
2002: Michel Burnier
[Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Drugs 2002;62 Spec No 1():21-9.
2002: Pascal Bovet; Michel Burnier; George Madeleine; Bernard Waeber; Fred Paccaud
Monitoring one-year compliance to antihypertension medication in the Seychelles.
Bulletin of the World Health Organization 2002;80(1):33-9.
2002: Marc Maillard; Grégoire Würzner; Jürg Nussberger; Catherine Centeno; Michel Burnier; Hans R Brunner
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Clinical pharmacology and therapeutics 2002;71(1):68-76.
2002: S Doll; Fred Paccaud; Pascal Bovet; Michel Burnier; Vincent Wietlisbach
Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):48-57.
2001: Michel Burnier
Novel angiotensin II inhibitors in cardiovascular medicine.
Expert opinion on investigational drugs 2001;10(11):1957-64.
2001: Grégoire Würzner; J C Gerster; Arnaud Chiolero; Marc Maillard; Claire-Lise Fallab-Stubi; Hans R Brunner; Michel Burnier
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
Journal of hypertension 2001;19(10):1855-60.
2001: Grégoire Würzner; Arnaud Chiolero; Marc Maillard; Jürg Nussberger; D Hayoz; Hans R Brunner; Michel Burnier
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Kidney international 2001;60(4):1469-76.
2001: D Sieg-Dobrescu; Michel Burnier; Daniel Hayoz; Hans R Brunner; Bernard Waeber
The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response.
Journal of hypertension 2001;19(8):1387-92.
2001: Qing Wang; Edith Hummler; Marc Maillard; Jürg Nussberger; Bernard C Rossier; Hans R Brunner; Michel Burnier
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Kidney international 2001;59(6):2216-21.
2001: Arnaud Chiolero; Grégoire Würzner; Michel Burnier
Renal determinants of the salt sensitivity of blood pressure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(3):452-8.
2001: Michel Burnier
Angiotensin II type 1 receptor blockers.
Circulation 2001;103(6):904-12.
2001: Michel Burnier; M P Schneider; Arnaud Chioléro; C L Stubi; Hans R Brunner
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.
Journal of hypertension 2001;19(2):335-41.
2000: Michel Burnier; M L Monod; Arnaud Chioléro; Marc Maillard; Jürg Nussberger; Hans R Brunner
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Journal of hypertension 2000;18(11):1657-64.
2000: Marc Maillard; J Rossat; Hans R Brunner; Michel Burnier
Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.
The Journal of pharmacology and experimental therapeutics 2000;295(2):649-54.
2000: Arnaud Chiolero; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Hypertension 2000;36(4):631-7.
2000: Daniel Hayoz; G Bizzini; Bernard Noël; Michèle Depairon; Michel Burnier; C Fauveau; A Rouillon; R Brouard; Hans R Brunner
Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon.
Rheumatology (Oxford, England) 2000;39(10):1132-8.
2000: V Gerc; B Favrat; H R Brunner; Michel Burnier
Is nurse-measured blood pressure a valid substitute for ambulatory blood pressure monitoring?
Blood pressure monitoring 2000;5(4):203-9.
2000: C L Stubi; Pierre Landry; C Pétignat; J Bille; Blaise Genton; R Darioli; Michel Burnier
Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.
Journal of travel medicine 2000;7(3):133-7.
2000: Marc Maillard; J Rossat; Jürg Nussberger; J Ramis; Caridad Pontes; Michel Burnier; Hans R Brunner
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Journal of cardiovascular pharmacology 2000;35(3):383-9.
2000: Arnaud Chiolero; Grégoire Würzner; Michel Burnier
[Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
Néphrologie 2000;21(8):425-30.
2000: Michel Burnier
Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension.
Blood pressure monitoring 2000;5 Suppl 1():S31-4.
2000: Qing Wang; Jean-Daniel Horisberger; Marc Maillard; Hans R Brunner; Bernard C Rossier; Michel Burnier
Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice.
Clinical and experimental pharmacology & physiology 2000;27(1-2):60-6.
1999: Marc Maillard; Lucia Mazzolai; V Daven; Catherine Centeno; Jürg Nussberger; Hans R Brunner; Michel Burnier
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
American journal of hypertension 1999;12(12 Pt 1-2):1201-8.
1999: Sylvain Pradervand; Qing Wang; Michel Burnier; Friedrich Beermann; Jean-Daniel Horisberger; Edith Hummler; Bernard C Rossier
A mouse model for Liddle's syndrome.
Journal of the American Society of Nephrology : JASN 1999;10(12):2527-33.
1999: Michel Burnier; A F Fricker; D Hayoz; Jürg Nussberger; Hans R Brunner
Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects.
European journal of clinical pharmacology 1999;55(9):633-7.
1999: Lucia Mazzolai; Michel Burnier
Comparative safety and tolerability of angiotensin II receptor antagonists.
Drug safety : an international journal of medical toxicology and drug experience 1999;21(1):23-33.
1999: J Rossat; Marc Maillard; Jürg Nussberger; Hans R Brunner; Michel Burnier
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Clinical pharmacology and therapeutics 1999;66(1):76-84.
1999: Michel Burnier; Hans R Brunner
Comparative antihypertensive effects of angiotensin II receptor antagonists.
Journal of the American Society of Nephrology : JASN 1999;10 Suppl 12():S278-82.
1999: Lucia Mazzolai; Marc Maillard; J Rossat; Jürg Nussberger; Hans R Brunner; Michel Burnier
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Hypertension 1999;33(3):850-5.
1999: Sylvain Pradervand; Pierre M Barker; Qing Wang; Stephen A Ernst; Friedrich Beermann; Barbara R Grubb; Michel Burnier; A Schmidt; R J Bindels; John Gatzy Jr; Bernard C Rossier; Edith Hummler
Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(4):1732-7.
1999: A Pechère-Bertschi; Jürg Nussberger; Michel Burnier
[Does constitutional hypotension exist?].
Therapeutische Umschau. Revue thérapeutique 1999;56(1):49-54.
1998: A F Fricker; Jürg Nussberger; S Meilenbrock; Hans R Brunner; Michel Burnier
Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
Kidney international 1998;54(6):2089-97.
1998: Michel Burnier; Hans R Brunner
Angiotensin II receptor antagonists in hypertension.
Kidney international. Supplement 1998;68():S107-11.
1998: Arnaud Chioléro; Michel Burnier
Pharmacology of valsartan, an angiotensin II receptor antagonist.
Expert opinion on investigational drugs 1998;7(11):1915-25.
1998: Michel Burnier
Sodium balance and hypertension: rare genetic disorders expose pathogenic mechanisms.
Experimental nephrology 1998;6(6):496-501.
1998: A Pechère-Bertschi; Jürg Nussberger; Jérôme Biollaz; M Fahti; E Grouzmann; T Morgan; Hans R Brunner; Michel Burnier
Circadian variations of renal sodium handling in patients with orthostatic hypotension.
Kidney international 1998;54(4):1276-82.
1998: Claire-Lise Fallab-Stubi; Jean-Pierre Zellweger; A Sauty; C Uldry; Danila Iorillo; Michel Burnier
Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1998;2(7):525-30.
1998: A Pechère-Bertschi; Jürg Nussberger; L Decosterd; C Armagnac; J Sissmann; M Bouroudian; Hans R Brunner; Michel Burnier
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Journal of hypertension 1998;16(3):385-93.
1997: R Weber; A Pechère-Bertschi; Daniel Hayoz; V Gerc; R Brouard; J P Lahmy; Hans R Brunner; Michel Burnier
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
Hypertension 1997;30(5):1121-7.
1997: Edith Hummler; Pierre M Barker; C Talbot; Qing Wang; Chantal Verdumo; B Grubb; John Gatzy Jr; Michel Burnier; Jean-Daniel Horisberger; Friedrich Beermann; Richard C Boucher; Bernard C Rossier
A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11710-5.
1997: V Gerc; A Schubert; Michel Burnier
[Differentiation between glomerular and non-glomerular erythrocyturia: what is the value of differential microhematuria diagnosis?].
Praxis 1997;86(31-32):1198-203.
1997: Michel Burnier; H R Brunner
Angiotensin II receptor antagonists - antihypertensive agents.
Expert opinion on investigational drugs 1997;6(5):489-500.
1996: J L Magnin; Laurent A Decosterd; C Centeno; Michel Burnier; J Diezi; Jérôme Biollaz
Determination of trace lithium in biological fluids using graphite furnace atomic absorption spectrophotometry: variability of urine matrices circumvented by cation exchange solid phase extraction.
Pharmaceutica acta Helvetiae 1996;71(4):237-46.
1996: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Experience with angiotensin II antagonists in hypertensive patients.
Clinical and experimental pharmacology & physiology 1996;23 Suppl 3():S142-6.
1995: Daniel Hayoz; R Weber; B Rutschmann; R Darioli; Michel Burnier; Bernard Waeber; Hans R Brunner
Postischemic blood flow response in hypercholesterolemic patients.
Hypertension 1995;26(3):497-502.
1995: E Delacrétaz; N de Quay; Bernard Waeber; Yvan Vial; P E Schulz; Michel Burnier; Hans R Brunner; H Bossart; N C Schaad
Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia.
Clinical science (London, England : 1979) 1995;88(6):607-10.
1994: Eric Grouzmann; P Werffeli-George; M Fathi; Michel Burnier; Bernard Waeber; Gérard Waeber
Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma.
The Journal of clinical endocrinology and metabolism 1994;79(6):1852-6.
1994: Hans R Brunner; E Delacrétaz; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists DuP 753 and TCV 116.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(9):S29-34.
1994: D Evequoz; Michel Burnier; M Niederberger; Hans R Brunner; Jürg Nussberger; Bernard Waeber
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Clinical and experimental pharmacology & physiology 1994;21(2):93-100.
1994: F Steinhäuslin; Michel Burnier; J L Magnin; Alain Munafo; T Buclin; J Diezi; Jérôme Biollaz
Fractional excretion of trace lithium and uric acid in acute renal failure.
Journal of the American Society of Nephrology : JASN 1994;4(7):1429-37.
1994: E Grouzmann; G Alvarez-Bolado; C Meyer; M C Osterheld; Michel Burnier; Hans R Brunner; Bernard Waeber
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue.
Peptides 1994;15(8):1377-82.
1993: Hans R Brunner; Jürg Nussberger; Michel Burnier; Bernard Waeber
Angiotensin II antagonists.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(6):1221-38.
1993: Michel Burnier; B Rutschmann; Jürg Nussberger; J Versaggi; S Shahinfar; Bernard Waeber; Hans R Brunner
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Hypertension 1993;22(3):339-47.
1992: E Grouzmann; E Comoy; P Walker; Michel Burnier; C Bohuon; Bernard Waeber; H Brunner
Production and characterization of four anti-neuropeptide Y monoclonal antibodies.
Hybridoma 1992;11(4):409-24.
1991: F Perret; V Mooser; Daniel Hayoz; Yanik Tardy; Jean-Jacques Meister; J D Etienne; P A Farine; A Marazzi; Michel Burnier; Jürg Nussberger
Evaluation of arterial compliance-pressure curves. Effect of antihypertensive drugs.
Hypertension 1991;18(4 Suppl):II77-83.
1991: Michel Burnier; M Ganslmayer; F Perret; M Porchet; T Kosoglou; A Gould; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):181-91.
1991: Michel Burnier; G Centeno; E Grouzmann; P Walker; Bernard Waeber; Hans R Brunner
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.
American journal of hypertension 1991;4(5 Pt 1):438-43.
1991: P Walker; Eric Grouzmann; Michel Burnier; B Waeber
The role of neuropeptide Y in cardiovascular regulation.
Trends in pharmacological sciences 1991;12(3):111-5.
1990: Bernard Waeber; Michel Burnier; Jürg Nussberger; Hans R Brunner
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S37-41.
1990: V Mooser; Jürg Nussberger; L Juillerat; Michel Burnier; Bernard Waeber; J Bidiville; N Pauly; Hans R Brunner
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Journal of cardiovascular pharmacology 1990;15(2):276-82.
1990: Bernard Waeber; Jürg Nussberger; Eric Grouzmann; Michel Burnier; Hans R Brunner
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):667-72.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S27-31.
1989: Bernard Waeber; Michel Burnier; F Perret; Jürg Nussberger; Hans R Brunner
Ambulatory blood pressure measurement and antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S33-9.
1989: Michel Burnier; V Mooser; J P Wauters; H K Marder; P De Vane; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Journal of cardiovascular pharmacology 1989;13(5):682-90.
1989: V Mooser; Michel Burnier; Jürg Nussberger; L Juillerat; Bernard Waeber; Hans R Brunner
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Journal of hypertension 1989;7(3):211-6.
1989: Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Pharmacokinetics of angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;28 Suppl 2():133S-139S; discussion 140S.
1989: Michel Burnier; V Mooser; Jürg Nussberger; Bernard Waeber; Hans R Brunner
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
British journal of clinical pharmacology 1989;27 Suppl 2():189S-197S.
1988: Michel Burnier; Bernard Waeber; Jean-François Aubert; Jürg Nussberger; Hans R Brunner
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
The American journal of physiology 1988;254(3 Pt 2):H509-16.
1988: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; D J Dipette; J F Burris; Hans R Brunner
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
The Journal of pharmacology and experimental therapeutics 1988;244(3):1109-15.
1987: Jean-François Aubert; Michel Burnier; Bernard Waeber; Jürg Nussberger; Hans R Brunner
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):681-5.